Co-sponsored by the Center and AIDS Project Los Angeles (APLA) and introduced by Assemblymember Mike A. Gipson (D-Carson), AB 2640 would ensure high-risk HIV-negative individuals receive information about all methods that reduce the risk of contracting HIV, including PrEP and PEP, during HIV post-test counseling.
"Alarmingly, awareness of PrEP and PEP is particularly low for those most at risk of HIV infection in California: Black and Latino men who are gay or bisexual," Center Medical Director Dr. Bob Bolan said. "This bill is a common sense approach to ensure people receive information about how to protect themselves. It will also encourage more open dialogue between medical providers and patients regarding sexual health."
PrEP is an HIV prevention strategy in which HIV-negative individuals take a daily medication to reduce their risk of becoming infected. PrEP has been shown to be up to 99% effective at preventing HIV transmission. PEP involves taking anti-HIV medications as soon as possible after a potential exposure to reduce the risk of becoming HIV-positive. According to a 2015 survey of gay and bisexual men by the California HIV/AIDS Research Program, only 1 in 10 respondents had ever used PrEP and nearly 85% had never talked to their doctor about PrEP.
Sign on to support AB 2640